NEU neuren pharmaceuticals limited

If we hit milestones (sales and progression) and receive fair...

  1. 1,369 Posts.
    lightbulb Created with Sketch. 580
    If we hit milestones (sales and progression) and receive fair treatment from the market, we will sit at $30-$40 this time next year, at which point $105 is totally within the bounds of a reasonable TO offer.

    If we clear P3 PMS, our SP will track north of $50 in my view and $105 will be beyond cheap.

    I think its a stretch from here but thats because we are mispriced in my view. I take your point though. I disagree that it will be "years" away - I think we could see an offer in that range next year if things go well.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.